Skip to main content

Advertisement

Table 2 Correlation between CDC20 expression and the clinicopathological characteristics of colorectal cancer patients

From: CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer

Characteristics CDC20 Chi-square
   Low or none High  
   No. cases (%) No. cases (%) testP-value
Gender Female 39 (30.0) 47 (41.2) 0.067
Male 91 (70.0) 67 (58.8)
Age (years) ≤ 50 43 (33.1) 42 (36.8) 0.538
> 50 87 (66.9) 72 (63.2)
Location colon 61 (46.9) 52 (45.6) 0.838
  rectal 69 (53.1) 62 (54.4)  
Clinical Stage I 26 (20.0) 16 (14.0) 0.008
  II 37 (28.5) 16 (14.0)  
  III 35 (26.9) 37 (32.5)  
  IV 32 (24.6) 45 (39.5)  
T classification T1+T2 29 (22.3) 27 (23.7) 0.799
  T3+T4 101 (77.7) 87 (76.3)  
N classification No 66 (50.8) 41 (36.0) 0.020
  Yes 64 (49.2) 73 (64.0)
M classification M0 98 (75.4) 69 (60.5) 0.013
M1 32 (24.6) 45 (39.5)
Pathologic Differentiation Poor 21 (16.2) 34 (29.8) 0.008
Moderate 93 (71.5) 75 (65.8)
Well 16 (12.3) 5 (4.4)
Vital status (as followed up) Alive 91 (70.0) 51 (44.7) <0.001
  Dead 39 (30.0) 63 (55.3)